| 101 |
12434406 | P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. | 2002 Dec |
1 |
| 102 |
11248673 | P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine. | 2001 Mar |
2 |
| 103 |
11396135 | Modulation of cancer cell multidrug resistance by an extract of Ficus citrifolia. | 2001 Mar-Apr |
1 |
| 104 |
11396174 | Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation. | 2001 Mar-Apr |
1 |
| 105 |
11399635 | P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival; Malignancy. | 2001 |
2 |
| 106 |
11482878 | 5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs. | 2001 May-Jun |
1 |
| 107 |
11585053 | The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin. | 2001 Sep 1 |
1 |
| 108 |
11606389 | The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein. | 2001 Oct 15 |
1 |
| 109 |
11783080 | [Subcellular distribution of daunorubicin in the P-glycoprotein-mediated multidrug-resistant cell line K562/ADR]. | 2001 May |
3 |
| 110 |
10601617 | Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates. | 2000 Jan-Feb |
2 |
| 111 |
10651723 | P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells. | 2000 Jan |
3 |
| 112 |
10681718 | Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin. | 2000 Feb |
1 |
| 113 |
10708754 | The effect of glutathione on the ATPase activity of MRP1 in its natural membranes. | 2000 Mar 3 |
1 |
| 114 |
10724034 | Chemoprotection of hematopoietic cells by a mutant P-glycoprotein resistant to a potent chemosensitizer of multidrug-resistant cancers. | 2000 Mar 1 |
1 |
| 115 |
10727524 | Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335). | 2000 Apr |
1 |
| 116 |
10772630 | In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. | 2000 May |
3 |
| 117 |
10773966 | Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome. | 2000 Jan |
2 |
| 118 |
10773967 | Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control. | 2000 Jan |
1 |
| 119 |
10778983 | Synergistic effect of prochlorperazine and dipyridamole on the cellular retention and cytotoxicity of doxorubicin. | 2000 Apr |
1 |
| 120 |
10783828 | Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP). | 2000 Apr |
1 |
| 121 |
10784624 | P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia. | 2000 May |
2 |
| 122 |
10784627 | Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. | 2000 May |
1 |
| 123 |
10865967 | P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy. | 2000 Jun |
2 |
| 124 |
10869171 | Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains. | 2000 Jul 4 |
3 |
| 125 |
10942898 | Modulation of daunorubicin cellular resistance by combination of P-glycoprotein blockers acting on drug efflux and intracellular drug sequestration in Golgi vesicles. | 2000 Sep 1 |
3 |
| 126 |
10974159 | Monitoring interactions at ATP-dependent drug efflux pumps. | 2000 Nov |
1 |
| 127 |
10978781 | Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line. | 2000 Sep |
2 |
| 128 |
11027568 | Cholesterol interaction with the daunorubicin binding site of P-glycoprotein. | 2000 Oct 5 |
2 |
| 129 |
11082465 | Influence of antipsychotic, antiemetic, and Ca(2+) channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation. | 2000 Dec |
1 |
| 130 |
11097180 | Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: evidence for half-of-the-sites reactivity. | 2000 Nov 1 |
2 |
| 131 |
11122104 | Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myeloblastic leukaemia. | 2000 Nov |
1 |
| 132 |
11197207 | Multidrug resistance of acute leukemia and a strategy to overcome it. | 2000 Dec |
2 |
| 133 |
11876999 | [Altered subcellular distribution of daunorubicin in the non-P-glycoprotein-mediated multidrug-resistant cell line HL-60/ADR]. | 2000 Jun |
1 |
| 134 |
27420927 | P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival. | 2000 |
2 |
| 135 |
9864431 | The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line. | 1999 Jan-Feb |
3 |
| 136 |
9933132 | Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia. | 1999 Jan |
2 |
| 137 |
10025900 | Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia? | 1999 Feb |
1 |
| 138 |
10079321 | Visualization of multidrug resistance in vivo. | 1999 Mar |
2 |
| 139 |
10342576 | Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells. | 1999 May |
4 |
| 140 |
10354400 | Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines. | 1999 Jun 3 |
1 |
| 141 |
10361105 | Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia. | 1999 Jun 15 |
1 |
| 142 |
10482990 | Idarubicin DNA intercalation is reduced by MRP1 and not Pgp. | 1999 Sep |
1 |
| 143 |
10496352 | Potent interaction of flavopiridol with MRP1. | 1999 Sep |
1 |
| 144 |
10500777 | Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML. | 1999 |
1 |
| 145 |
10561359 | Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420. | 1999 Sep |
1 |
| 146 |
10665657 | Interaction of docetaxel ("Taxotere") with human P-glycoprotein. | 1999 Dec |
1 |
| 147 |
9430558 | Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. | 1998 Jan |
7 |
| 148 |
9458355 | Differential expression and activity of P-glycoprotein and multidrug resistance-associated protein in CD34-positive KG1a leukemic cells. | 1998 Feb |
1 |
| 149 |
9504636 | MDR1 gene expression and drug resistance of AML cells. | 1998 Mar |
2 |
| 150 |
9558371 | Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides. | 1998 May 1 |
1 |